Cargando…
Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031888/ https://www.ncbi.nlm.nih.gov/pubmed/35454955 http://dx.doi.org/10.3390/cancers14081957 |
| _version_ | 1784692503618781184 |
|---|---|
| author | Bar-Sela, Gil Cohen, Idan Campisi-Pinto, Salvatore Lewitus, Gil M. Oz-Ari, Lanuel Jehassi, Ayellet Peer, Avivit Turgeman, Ilit Vernicova, Olga Berman, Paula Wollner, Mira Moskovitz, Mor Meiri, David |
| author_facet | Bar-Sela, Gil Cohen, Idan Campisi-Pinto, Salvatore Lewitus, Gil M. Oz-Ari, Lanuel Jehassi, Ayellet Peer, Avivit Turgeman, Ilit Vernicova, Olga Berman, Paula Wollner, Mira Moskovitz, Mor Meiri, David |
| author_sort | Bar-Sela, Gil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9031888 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90318882022-04-23 Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447 Bar-Sela, Gil Cohen, Idan Campisi-Pinto, Salvatore Lewitus, Gil M. Oz-Ari, Lanuel Jehassi, Ayellet Peer, Avivit Turgeman, Ilit Vernicova, Olga Berman, Paula Wollner, Mira Moskovitz, Mor Meiri, David Cancers (Basel) Correction MDPI 2022-04-13 /pmc/articles/PMC9031888/ /pubmed/35454955 http://dx.doi.org/10.3390/cancers14081957 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Bar-Sela, Gil Cohen, Idan Campisi-Pinto, Salvatore Lewitus, Gil M. Oz-Ari, Lanuel Jehassi, Ayellet Peer, Avivit Turgeman, Ilit Vernicova, Olga Berman, Paula Wollner, Mira Moskovitz, Mor Meiri, David Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447 |
| title | Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447 |
| title_full | Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447 |
| title_fullStr | Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447 |
| title_full_unstemmed | Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447 |
| title_short | Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447 |
| title_sort | correction: bar-sela et al. cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome. cancers 2020, 12, 2447 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031888/ https://www.ncbi.nlm.nih.gov/pubmed/35454955 http://dx.doi.org/10.3390/cancers14081957 |
| work_keys_str_mv | AT barselagil correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT cohenidan correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT campisipintosalvatore correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT lewitusgilm correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT ozarilanuel correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT jehassiayellet correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT peeravivit correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT turgemanilit correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT vernicovaolga correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT bermanpaula correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT wollnermira correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT moskovitzmor correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 AT meiridavid correctionbarselaetalcannabisconsumptionusedbycancerpatientsduringimmunotherapycorrelateswithpoorclinicaloutcomecancers2020122447 |